Keskinidou, C.; Vassiliou, A.G.; Zacharis, A.; Jahaj, E.; Gallos, P.; Dimopoulou, I.; Orfanos, S.E.; Kotanidou, A.
Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone. Diagnostics 2021, 11, 1249.
https://doi.org/10.3390/diagnostics11071249
AMA Style
Keskinidou C, Vassiliou AG, Zacharis A, Jahaj E, Gallos P, Dimopoulou I, Orfanos SE, Kotanidou A.
Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone. Diagnostics. 2021; 11(7):1249.
https://doi.org/10.3390/diagnostics11071249
Chicago/Turabian Style
Keskinidou, Chrysi, Alice G. Vassiliou, Alexandros Zacharis, Edison Jahaj, Parisis Gallos, Ioanna Dimopoulou, Stylianos E. Orfanos, and Anastasia Kotanidou.
2021. "Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone" Diagnostics 11, no. 7: 1249.
https://doi.org/10.3390/diagnostics11071249
APA Style
Keskinidou, C., Vassiliou, A. G., Zacharis, A., Jahaj, E., Gallos, P., Dimopoulou, I., Orfanos, S. E., & Kotanidou, A.
(2021). Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone. Diagnostics, 11(7), 1249.
https://doi.org/10.3390/diagnostics11071249
